|
| 36803110 | Progress and Pitfalls in the Provision of Quality Care for Adults With Attention Deficit Hyperactivity Disorder in Primary Care. | J Atten Disord | 2023 |
| 34806909 | Economic burden of attention-deficit/hyperactivity disorder among adults in the United States: a societal perspective. | J Manag Care Spec Pharm | 2022 |
| 35652746 | Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder: Results of 2 Phase 3, Randomized, Double-blind, Multicenter, Placebo-Controlled Trials. | J Clin Psychopharmacol | 2022 |
| 35697401 | Updates in Pharmacologic Strategies in Adult Attention-Deficit/Hyperactivity Disorder. | Child Adolesc Psychiatr Clin N Am | 2022 |
| 35068300 | Economic burden of attention-deficit/hyperactivity disorder among children and adolescents in the United States: a societal perspective. | J Med Econ | 2022 |
| 34166067 | The Validity of the World Health Organization Adult Attention-Deficit/Hyperactivity Disorder Self-Report Screening Scale for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition in Adolescence. | J Child Adolesc Psychopharmacol | 2021 |
| 33724251 | Dasotraline in adults with attention deficit hyperactivity disorder: a placebo-controlled, fixed-dose trial. | Int Clin Psychopharmacol | 2021 |
| 34232582 | A Placebo-Controlled Trial of Lisdexamfetamine in the Treatment of Comorbid Sluggish Cognitive Tempo and Adult ADHD. | J Clin Psychiatry | 2021 |
| 27521574 | Executive Functioning Outcomes Over 6 Months of Atomoxetine for Adults With ADHD: Relationship to Maintenance of Response and Relapse Over the Subsequent 6 Months After Treatment. | J Atten Disord | 2020 |
| 33095375 | Screening for Adult ADHD. | Curr Psychiatry Rep | 2020 |
| 32423239 | <i>Post hoc</i> Responder and Remission Analyses from Two Studies of SHP465 Mixed Amphetamine Salts Extended-Release Among Adults with Attention-Deficit/Hyperactivity Disorder. | J Child Adolesc Psychopharmacol | 2020 |
| 29804496 | Informativeness of Self-Reports of ADHD Symptoms in Monitoring Response to Stimulant Treatment in Clinically Referred Adults With ADHD. | J Atten Disord | 2020 |
| 30296883 | The Relationship Between Executive Function Deficits and <i>DSM</i>-5-Defined ADHD Symptoms. | J Atten Disord | 2020 |
| 28413925 | Triple-Bead Mixed Amphetamine Salts (SHP465) in Adults With ADHD: Results of a Phase 3, Double-Blind, Randomized, Forced-Dose Trial. | J Atten Disord | 2020 |
| 28412886 | A Long-Term, Open-Label, Safety Study of Triple-Bead Mixed Amphetamine Salts (SHP465) in Adults With ADHD. | J Atten Disord | 2020 |
| 25907673 | Pilot Study of Droxidopa With Carbidopa in Adults With ADHD. | J Atten Disord | 2019 |
| 30239073 | Establishing US norms for the Adult ADHD Self-Report Scale (ASRS-v1.1) and characterising symptom burden among adults with self-reported ADHD. | Int J Clin Pract | 2019 |
| 31340712 | Healthcare provider perspectives on diagnosing and treating adults with attention-deficit/hyperactivity disorder. | Postgrad Med | 2019 |
| 30694697 | Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial. | J Child Adolesc Psychopharmacol | 2019 |
| 30511593 | The Adult ADHD Quality Measures Initiative. | J Atten Disord | 2019 |
| 30407687 | Evidence for the reliability and preliminary validity of the Adult ADHD Self-Report Scale v1.1 (ASRS v1.1) Screener in an adolescent community sample. | Int J Methods Psychiatr Res | 2019 |
| 29419345 | Validation of the Expanded Versions of the Adult ADHD Self-Report Scale v1.1 Symptom Checklist and the Adult ADHD Investigator Symptom Rating Scale. | J Atten Disord | 2019 |
| 29172673 | How Informative Are Self-Reported Adult Attention-Deficit/Hyperactivity Disorder Symptoms? An Examination of the Agreement Between the Adult Attention-Deficit/Hyperactivity Disorder Self-Report Scale V1.1 and Adult Attention-Deficit/Hyperactivity Disorder Investigator Symptom Rating Scale. | J Child Adolesc Psychopharmacol | 2018 |
| 30210370 | Cogmed Working Memory Training Presents Unique Implementation Challenges in Adults With ADHD. | Front Psychiatry | 2018 |
| 30381800 | A Low-Level Perceptual Correlate of Behavioral and Clinical Deficits in ADHD. | Comput Psychiatr | 2018 |
| 29661516 | Lisdexamfetamine Targets Amygdala Mechanisms That Bias Cognitive Control in Attention-Deficit/Hyperactivity Disorder. | Biol Psychiatry Cogn Neurosci Neuroimaging | 2018 |
| 29177453 | Test-retest reliability of the adult ADHD Self-Report Scale (ASRS) v1.1 Screener in non-ADHD controls from a primary care physician practice. | Fam Pract | 2018 |
| 23657761 | Effectiveness and Duration of Effect of Open-Label Lisdexamfetamine Dimesylate in Adults With ADHD. | J Atten Disord | 2017 |
| 28384801 | The World Health Organization Adult Attention-Deficit/Hyperactivity Disorder Self-Report Screening Scale for DSM-5. | JAMA Psychiatry | 2017 |
| 28211596 | The structure of adult ADHD. | Int J Methods Psychiatr Res | 2017 |
| 27935735 | Pharmacokinetic and Pharmacodynamic Properties of Lisdexamfetamine in Adults with Attention-Deficit/Hyperactivity Disorder. | J Child Adolesc Psychopharmacol | 2017 |
| 24464328 | Treatment With Lisdexamfetamine Dimesylate Improves Self- and Informant-Rated Executive Function Behaviors and Clinician- and Informant-Rated ADHD Symptoms in Adults: Data From a Randomized, Double-Blind, Placebo-Controlled Study. | J Atten Disord | 2017 |
| 27027541 | Neural Correlates of Symptom Improvement Following Stimulant Treatment in Adults with Attention-Deficit/Hyperactivity Disorder. | J Child Adolesc Psychopharmacol | 2016 |
| 27105181 | The Groundskeeper Gaming Platform as a Diagnostic Tool for Attention-Deficit/Hyperactivity Disorder: Sensitivity, Specificity, and Relation to Other Measures. | J Child Adolesc Psychopharmacol | 2016 |
| 25563210 | Validation of the adult attention-deficit/hyperactivity disorder quality-of-life scale in European patients: comparison with patients from the USA. | Atten Defic Hyperact Disord | 2015 |
| 22617860 | A 9-week, randomized, double-blind, placebo-controlled, parallel-group, dose-finding study to evaluate the efficacy and safety of modafinil as treatment for adults with ADHD. | J Atten Disord | 2014 |
| 25621186 | Our current understanding of adult ADHD. | Innov Clin Neurosci | 2014 |
| 25295646 | Clinical effects of lisdexamfetamine and mixed amphetamine salts immediate release in adult ADHD: results of a crossover design clinical trial. | Postgrad Med | 2014 |
| 25295645 | Attention benefits after a single dose of metadoxine extended release in adults with predominantly inattentive ADHD. | Postgrad Med | 2014 |
| 24977716 | Executive function in adults with attention-deficit/hyperactivity disorder during treatment with atomoxetine in a randomized, placebo-controlled, withdrawal study. | J Clin Psychopharmacol | 2014 |
| 25148243 | Atomoxetine effects on executive function as measured by the BRIEF--a in young adults with ADHD: a randomized, double-blind, placebo-controlled study. | PLoS One | 2014 |
| 24363557 | Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: the effects of age and sex in pivotal trials of lisdexamfetamine dimesylate. | Neuropsychiatr Dis Treat | 2014 |
| 24103255 | The effects of temporally secondary co-morbid mental disorders on the associations of DSM-IV ADHD with adverse outcomes in the US National Comorbidity Survey Replication Adolescent Supplement (NCS-A). | Psychol Med | 2014 |
| 23277268 | Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlled clinical trial. | J Clin Psychopharmacol | 2013 |
| 24106804 | Self-Reported quality of life in adults with attention-deficit/hyperactivity disorder and executive function impairment treated with lisdexamfetamine dimesylate: a randomized, double-blind, multicenter, placebo-controlled, parallel-group study. | BMC Psychiatry | 2013 |
| 23933905 | Efficacy of metadoxine extended release in patients with predominantly inattentive subtype attention-deficit/hyperactivity disorder. | Postgrad Med | 2013 |
| 23945447 | Lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder who report clinically significant impairment in executive function: results from a randomized, double-blind, placebo-controlled study. | J Clin Psychiatry | 2013 |
| 23648011 | Baseline characteristics of European and non-European adult patients with attention deficit hyperactivity disorder participating in a placebo-controlled, randomized treatment study with atomoxetine. | Child Adolesc Psychiatry Ment Health | 2013 |
| 21748252 | Efficacy and safety of the novel α⿿β⿿ neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study. | Psychopharmacology (Berl) | 2012 |
| 23290324 | A randomized, double-blind, placebo-controlled, multicenter study evaluating the efficacy, safety, and tolerability of extended-release metadoxine in adults with attention-deficit/hyperactivity disorder. | J Clin Psychiatry | 2012 |